Trial Parameters
Brief Summary
The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.
Eligibility Criteria
Inclusion Criteria: * Informed consent is obtained from the participant or from the parent/ legal guardian * The participant is 2 months or older * The participant is diagnosed with a genetic disease * The participant is a first degree relative of a subject diagnosed with a genetic disease Exclusion Criteria: * Informed consent is not obtained from the participant or from the parent/ legal guardian * The participant is younger than 2 months * The participant is not diagnosed with a genetic disease * The participant is not a first degree relative of a subject diagnosed with a genetic disease